| Active Not Recruiting | Starring Optical Coherence Tomography During Percutaneous Coronary Intervention Guidance NCT07182799 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Mini-Crush Or Controlled Balloon-Crush For True Coronary Bifurcation Lesions NCT06880978 | Istanbul Mehmet Akif Ersoy Educational and Training Hospital | — |
| Recruiting | Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation NCT06308952 | Duan Chuanzhi | Phase 4 |
| Recruiting | Flow Patterns and Stent Thrombosis NCT06700018 | Queen Mary University of London | — |
| Completed | TADCLOT- a Double Blind Randomized Controlled Trial NCT06318481 | National Institute of Cardiovascular Diseases, Pakistan | Phase 3 |
| Completed | TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk NCT06667349 | National Institute of Cardiovascular Diseases, Pakistan | Phase 4 |
| Recruiting | Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mes NCT05244629 | Rigshospitalet, Denmark | N/A |
| Recruiting | What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? NCT04436978 | St. Antonius Hospital | Phase 4 |
| Recruiting | COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting w NCT06075602 | Luzerner Kantonsspital | — |
| Recruiting | SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Tr NCT04988685 | Luzerner Kantonsspital | — |
| Completed | Evaluating Pharmacogenomic Variants for Cardiology Therapeutics NCT04702113 | Cipherome, Inc. | N/A |
| Completed | Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects NCT04580602 | Cipherome, Inc. | — |
| Unknown | CONNECT DES Registrty NCT04715594 | Yonsei University | — |
| Completed | Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO) NCT03209843 | Poitiers University Hospital | N/A |
| Completed | Leaders Free III: BioFreedom™ Clinical Trial NCT03118895 | Biosensors Europe SA | N/A |
| Completed | veRy Thin Stents for Patients With Left mAIn or bifurcatioN in Real Life: the RAIN a Multicenter Study NCT03544294 | A.O.U. Città della Salute e della Scienza | — |
| Completed | Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients U NCT02617290 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Completed | Register of Patients Benefiting From a Coronary Bifurcation Angioplasty at the University Hospital of Nîmes an NCT04011046 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Definite Stent Thrombosis in Comatose Out of Hospital Cardiac Arrest Survivors NCT03312296 | University Medical Centre Ljubljana | — |
| Completed | Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China NCT03491891 | The First Hospital of Jilin University | — |
| Completed | XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study NCT01894152 | Abbott Medical Devices | — |
| Completed | XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study NCT01249027 | Abbott Medical Devices | — |
| Completed | EXCEL Clinical Trial (Universal Registry) NCT01205789 | Abbott Medical Devices | — |
| Completed | EXCEL Clinical Trial NCT01205776 | Abbott Medical Devices | N/A |
| Completed | XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan NCT01086228 | Abbott Medical Devices | — |
| Completed | Mechanism Of Stent Thrombosis (MOST) Study NCT01410539 | Careggi Hospital | Phase 4 |
| Completed | Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients NCT00998127 | Icahn School of Medicine at Mount Sinai | — |
| Completed | Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation NCT00822536 | Assistance Publique - Hôpitaux de Paris | Phase 4 |
| Completed | Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis NCT00914368 | Uppsala University | Phase 2 |
| Completed | XIENCE V: SPIRIT WOMEN Sub-study NCT01182428 | Abbott Medical Devices | Phase 4 |
| Completed | REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS) NCT01231035 | Careggi Hospital | — |
| Completed | Stent Thrombosis In Acute Coronary Syndromes NCT00931502 | University of California, Davis | — |
| Completed | VerifyNow French Registry NCT00753753 | Association Pour le Développement des Soins Cardiologiques de la ville de Chartres | — |
| Terminated | PeriOperative Bridging - Perioperative Anticoagulation in the Setting of Recent Intracoronary Drug Eluting Ste NCT00606151 | The Cleveland Clinic | — |
| Completed | Prospective Clinical Observational Registry Including Consecutive Patients With In-stent Restenosis or Stent T NCT00647504 | Tampere University | — |
| Completed | XIENCE V: SPIRIT WOMEN NCT00496938 | Abbott Medical Devices | Phase 4 |
| Unknown | Long-Term Safety of Drug Eluting Stents in the "Real World" (FReIburger STent Registry) NCT00905008 | University Hospital Freiburg | — |
| Completed | SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) NCT00180479 | Abbott Medical Devices | Phase 3 |
| Completed | PTRG-DES Consortium NCT04734028 | Gyeongsang National University Hospital | — |
| Completed | Glasgow Natural History Study Of Covered Coronary Interventions NCT03862352 | NHS National Waiting Times Centre Board | — |